# Business Angels Switzerland (BAS)

> Business Angels Switzerland (BAS) is a VC fund backing Health Care. See 117 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Zürich, Switzerland
- Total investments: 117
- Last investment: May 2025
- Lead investor: 31%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/business-angels-switzerland
- Website: http://www.businessangels.ch/

Business Angels Switzerland (BAS) is an association giving young entrepreneurs the opportunity to present their projects and start-up companies to seasoned investors and successful entrepreneurs. The aim of the presentation is to obtain financing for the project, coaching, or both.The association's 69 members are split into two sections:the Swiss-German one, based in Zurich, and the Suisse Romande one, based in Lausanne.BAS is neither an investment fund nor a holding company: the decisions to invest are made by its members on a personal basis. BAS is thus not involved at all in its members’ investments.

## Contacts

5 contacts available for Business Angels Switzerland (BAS). Shizune tracks 3 team members at Business Angels Switzerland (BAS). Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/business-angels-switzerland-bas?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 21 | 18% |
| Software | 18 | 15% |
| Medical Device | 13 | 11% |
| Biotechnology | 11 | 9% |
| Information Technology | 11 | 9% |

140 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 42 | 36% |
| Funding Round | 19 | 16% |
| Venture - Series Unknown | 16 | 14% |
| Pre-Seed | 14 | 12% |
| Series A | 9 | 8% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 75 | 64% |
| Germany | 4 | 3% |
| France | 2 | 2% |
| Belgium | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Stéphane Rousset | Member, Board of Directors | 0 | https://shizune.co/investors/profile/stephane-rousset |
| Caroline Gueissaz | General Manager | 14 | https://shizune.co/investors/profile/caroline-gueissaz |
| Jacques Billy | Investor - Committee Member | 0 | https://shizune.co/investors/profile/jacques-billy |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| KOMP-ACT | KOMP-ACT has developed Modula, an innovative electric actuator solution that is poised to electrify the next generation of the industrial machines in the automation industry for the benefits of the machines builders, end-users and last but not least our environment towards an important reduction of CO2 emissions. | $2M |  | May 13, 2025 |  |
| qCella | qCella Impregnate natural fibers with copper and utilize them to create heating mats that outperform commercially available heating wires. When linked to a power source (e.g., a battery), the mats have the right electrical resistance over the entire structure, allowing them to heat uniformly. | $1.4M | Pre-Seed | Jan 21, 2025 |  |
| macu4 | We make innovative trendy orthopedic solutions by providing easy, fast, and gentle access to lightweight & breathable 3D printed devices. |  | Venture - Series Unknown | Dec 20, 2024 |  |
| INOFEA | INOFEA AG is a biotech company that offers a platform technology capable to fit enzymes in vivo and process conditions. The company was founded in 2014 and is headquartered in Basel, Switzerland. |  | Venture - Series Unknown | Nov 29, 2024 |  |
| Provuu | Provuu is a manufacturing company that designs and retails outdoor wearable VR goggles and sporting goods. |  | Pre-Seed | Oct 17, 2024 |  |
| Regenosca | Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair. Regenosca brings regeneration over scarring with our medical devices. | $1.1M | Pre-Seed | Jul 22, 2024 |  |
| Bewelab SA | Neuria is an interdisciplinary team at the interface between neuroscience, psychology, and computer science, which develops interventions to improve or restore your health |  | Seed | Jul 12, 2024 |  |
| Bewelab SA | Neuria is an interdisciplinary team at the interface between neuroscience, psychology, and computer science, which develops interventions to improve or restore your health | $750K | Pre-Seed | Jul 12, 2024 |  |
| Perseo pharma | Perseo pharma’s therapeutic enzymes, with their stealth coating, are able to invisibly reach their targets so as to slay the disease. |  | Venture - Series Unknown | Jul 08, 2024 |  |
| MOOST | MOOST offers packages to automate routines at home. These automations help users save energy, save time, improve security, increase comfort or all of them together. The core is a personalised recommender engine which helps users get the Most Out Of their Smart Things (MOOST). The machine learning capabilities and recommender engine is also offeredas a service to other smart home platforms (no personal data is ever shared among different platforms). |  | Venture - Series Unknown | Jun 26, 2024 |  |

10 of 117 investments shown.

## Co-investors
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund, 12 deals together
- [Verve Ventures](https://shizune.co/investors/profile/verve-ventures) — VC Fund, 10 deals together
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund, 8 deals together
- [4FOX Ventures](https://shizune.co/investors/profile/4fo-ventures) — VC Fund, 7 deals together
- [GoBeyond](https://shizune.co/investors/profile/go-beyond) — VC Fund, 6 deals together
- [3wVentures](https://shizune.co/investors/profile/3wventures-com) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Business Angels Switzerland (BAS) invest in?

Business Angels Switzerland (BAS) invests primarily in Health Care, Software and Medical Device startups, most often at Seed and Funding Round stage. Most of the 117 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Business Angels Switzerland (BAS)?

Public channels for Business Angels Switzerland (BAS) include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Business Angels Switzerland (BAS)?

The team at Business Angels Switzerland (BAS) includes Stéphane Rousset (Member, Board of Directors), Caroline Gueissaz (General Manager) and Jacques Billy (Investor - Committee Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co